Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hmbromide
2. Homatropine Methylbromide
3. Homatropine Methylbromide Iodide, (3(r)-endo)-isomer
4. Homatropine Methylbromide Iodide, (3(s)-endo)-isomer
5. Homatropine Methylbromide, (3(r)-endo)-isomer
6. Homatropine Methylbromide, (3(s)-endo)-isomer
7. Homatropine Methylbromide, Endo-(+-)-isomer
1. Homatropine Methylbromide
2. Homatropine Methobromide
3. Omatropina Metilbromuro
4. Methylhomatropine Bromide
5. 80-49-9
6. 8-methylhomatropinium Bromide
7. Tropinium Methobromide Mandelate
8. Homatropine Methyl Bromide
9. Methylhomatropinum Bromatum
10. Methylbromure D'homatropine
11. 3-alpha-hydroxy-8-methyl-1-alpha-h,5-alpha-h-tropanium Bromide Mandelate
12. Nsc34399
13. Schembl77827
14. Chebi:50373
15. Akos015896228
16. Db00725
17. 3-[2-hydroxy(phenyl)acetoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane Bromide
18. Ncgc00094694-01
19. Ncgc00094694-02
20. Db-056442
21. D90875
22. H-2560
Molecular Weight | 370.3 g/mol |
---|---|
Molecular Formula | C17H24BrNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 369.09396 g/mol |
Monoisotopic Mass | 369.09396 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 374 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Used in conjunction with antacids or histamine H2-receptor antagonists in the treatment of peptic ulcers, gastric ulcers and duodenal ulcers, to reduce further gastric acid secretion and delay gastric emptying.
Homatropine methylbromide belongs to the group of medicines called anti-muscarinics. Homatropine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03B - Belladonna and derivatives, plain
A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds
A03BB06 - Homatropine methylbromide
Homatropine is a quaternary ammonium muscarinic acetylcholine receptor antagonist. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins. Homatropine methylbromide inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves as well as on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These postganglionic receptor sites are present in the autonomic effector cells of the smooth muscle, cardiac muscle, sinoatrial and atrioventricular nodes, and exocrine glands. Depending on the dose, anticholinergics may reduce the motility and secretory activity of the gastrointestinal system, and the tone of the ureter and urinary bladder and may have a slight relaxant action on the bile ducts and gallbladder.
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
29
PharmaCompass offers a list of Homatropine Methylbromide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Homatropine Methylbromide manufacturer or Homatropine Methylbromide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Homatropine Methylbromide manufacturer or Homatropine Methylbromide supplier.
PharmaCompass also assists you with knowing the Homatropine Methylbromide API Price utilized in the formulation of products. Homatropine Methylbromide API Price is not always fixed or binding as the Homatropine Methylbromide Price is obtained through a variety of data sources. The Homatropine Methylbromide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE, including repackagers and relabelers. The FDA regulates HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE supplier is an individual or a company that provides HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE active pharmaceutical ingredient (API) or HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE finished formulations upon request. The HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers may include HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE API manufacturers, exporters, distributors and traders.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE DMF (Drug Master File) is a document detailing the whole manufacturing process of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE active pharmaceutical ingredient (API) in detail. Different forms of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE DMFs exist exist since differing nations have different regulations, such as HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE DMF submitted to regulatory agencies in the US is known as a USDMF. HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE USDMF includes data on HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers with USDMF on PharmaCompass.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP of the European Pharmacopoeia monograph is often referred to as a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE Certificate of Suitability (COS). The purpose of a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE to their clients by showing that a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP has been issued for it. The manufacturer submits a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP (COS) as part of the market authorization procedure, and it takes on the role of a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP holder for the record. Additionally, the data presented in the HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE DMF.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers with CEP (COS) on PharmaCompass.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE written confirmation (HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE WC) is an official document issued by a regulatory agency to a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE manufacturer, verifying that the manufacturing facility of a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE APIs or HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE finished pharmaceutical products to another nation, regulatory agencies frequently require a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE WC (written confirmation) as part of the regulatory process.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE suppliers with NDC on PharmaCompass.
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE GMP manufacturer or HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE GMP API supplier for your needs.
A HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CoA (Certificate of Analysis) is a formal document that attests to HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE's compliance with HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE specifications and serves as a tool for batch-level quality control.
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CoA mostly includes findings from lab analyses of a specific batch. For each HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE may be tested according to a variety of international standards, such as European Pharmacopoeia (HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE EP), HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (HOMATROPINE METHYLBROMIDE AND HYDROCODONE BITARTRATE USP).